Biocryst Pharmaceuticals Inc (BCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Deerfield Management

James E. Flynn

12,169,000 $92,362,710 +160% 1.41%
2.
Kynam Capital

Derrick Tang

9,390,270 $71,272,149 +11% 5.31%
3.
Alkeon Capital Management

Panayotis Takis Sparaggis

5,464,021 $41,471,919 -5% 0.06%
4.
Arrowstreet Capital

Peter Rathjens, Bruce Clarke And John Campbell

5,225,986 $39,665,234 +23% 0.03%
5.
Two Sigma Advisors

John Overdeck And David Siegel

4,240,712 $32,187,004 +1% 0.06%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$6.36 7,861 $49,995.96 44,951 2024-05-30 Filing
$6.40 2,500 $16,000.00 2,500 2024-05-24 Filing
$6.38 5,000 $31,900.00 86,818 2024-05-20 Filing
$6.25 15,000 $93,750.00 66,997 2024-05-20 Filing
$5.57 36,300 $202,191.00 266,744 2024-05-14 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$7.14 9,600 $68,544.00 30,642 2025-11-13 Filing
$8.51 70,000 $595,868.00 65,352 2025-08-13 Filing
$7.54 7,000 $52,780.00 86,638 2024-12-13 Filing
$6.32 8,600 $54,352.00 27,831 2024-06-24 Filing
$6.00 4,689 $28,134.00 27,742 2024-06-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 21,790,881 $165,392,786 0%
2. 21,245,876 $161,256,203 0%
3. 9,807,438 $74,438,454 0%
4. 5,967,737 $45,295,124 0.01%
5. 5,202,959 $39,490,462 0%
News See All